UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Vascular Endothelial Growth Factor Gene Polymorphisms Are Associated with Prognosis in Ovarian Cancer

Clinical cancer research, 2007-02, Vol.13 (3), p.898-901

2007

Volltextzugriff (PDF)

prognostic gene expression index in ovarian cancer--validation across different independent data sets

The Journal of pathology, 2009-06, Vol.218 (2), p.273-280

2009

Volltextzugriff (PDF)

Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors

Cancer research (Chicago, Ill.), 2006-11, Vol.66 (22), p.10795-10804

2006

Volltextzugriff (PDF)

An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian Carcinoma

Clinical cancer research, 2007-01, Vol.13 (2), p.458-466

2007

Volltextzugriff (PDF)

Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cells

Journal of molecular medicine (Berlin, Germany), 2005-06, Vol.83 (6), p.457-467

2005

Volltextzugriff (PDF)

Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients

BMC cancer, 2005-10, Vol.5 (1), p.133-133, Article 133

2005

Volltextzugriff (PDF)

The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer

European journal of obstetrics & gynecology and reproductive biology, 2007-02, Vol.130 (2), p.249-257

2007

Volltextzugriff (PDF)

Altered Expression Pattern of Topoisomerase IIα, in Ovarian Tumor Epithelial and Stromal Cells after Platinum-Based Chemotherapy

Neoplasia (New York, N.Y.), 2006-01, Vol.8 (1), p.38-45

2006

Volltextzugriff (PDF)

Pelvic Exenteration in Advanced Gynecologic Malignancies – Who Will Benefit?

Anticancer research, 2021-06, Vol.41 (6), p.3037-3043

2021

Volltextzugriff (PDF)

Anterior enterocele after cystectomy: case report and review of the literature

Archives of gynecology and obstetrics, 2024-07, Vol.310 (1), p.11-21

2024

Volltextzugriff (PDF)

Soluble heat-shock protein 27 in blood serum is a non-invasive prognostic biomarker for ovarian cancer

European journal of obstetrics & gynecology and reproductive biology, 2020-12, Vol.255, p.154-159

2020

Volltextzugriff (PDF)

Risk Factors for Severe Complications in Ovarian Cancer Surgery

In vivo (Athens), 2020-11, Vol.34 (6), p.3361-3365

2020

Volltextzugriff (PDF)

Analysis of heat shock protein HSP27 secretion in an ovarian cancer cell model and detection of cell-free HSP27 in patient blood serum sample

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e16570-e16570

2015

Volltextzugriff (PDF)

Polymorphism of IL-1α, IL-1β and IL-10 in patients with advanced ovarian cancer: Results of a prospective study with 147 patients

Gynecologic oncology, 2007, Vol.104 (3), p.680-685

2007

Volltextzugriff (PDF)

Topoisomerase IIα mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis

Modern pathology, 2009-04, Vol.22 (4), p.579-588

2009

Volltextzugriff (PDF)

Expression of multidrug resistance-associated protein 1 in invasive ovarian carcinoma: implication for prognosis

Histopathology, 2009-05, Vol.54 (6), p.657-666

2009

Volltextzugriff (PDF)

Expression of IL-10 in Patients with Ovarian Carcinoma

Anticancer research, 2006-03, Vol.26 (2C), p.1715-1718

2006

Volltextzugriff (PDF)

Bildgebung des Beckenbodens: Die Sicht der Gynäkologie

Radiologie (Heidelberg, Germany), 2023-11, Vol.63 (11), p.821-826

2023

Volltextzugriff (PDF)

Lower Genital Tract Melanomas: Staging, Predictors of Outcome, and New Therapeutic Options

Anticancer research, 2021-02, Vol.41 (2), p.999-1004

2021

Volltextzugriff (PDF)

Polymorphism of IL-1 receptor antagonist gene: role in cancer

Anticancer research, 2002-11, Vol.22 (6A), p.3421

2002

Volltextzugriff (PDF)

Topoisomerase II mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis

Modern pathology, 2009-04, Vol.22 (4), p.579-588

2009

Volltextzugriff (PDF)

Polymorphism of IL-1alpha, IL-1beta and IL-10 in patients with advanced ovarian cancer: results of a prospective study with 147 patients

Gynecologic oncology, 2007-03, Vol.104 (3), p.680-685

2007

Volltextzugriff (PDF)

Altered Expression Pattern of Topoisomerase IIα in Ovarian Tumor Epithelial and Stromal Cells after Platinum-Based Chemotherapy1

Neoplasia (New York, N.Y.), 2006-01, Vol.8 (1), p.38-45

2006

Volltextzugriff (PDF)

Preoperative determination of CASA (Cancer Associated Serum Antigen) and CA-125 for the discrimination between benign and malignant pelvic tumor mass: a prospective study

Anticancer research, 2003-03, Vol.23 (2A), p.1115

2003

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(32)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Vascular Endothelial Growth Factor Gene Polymorphisms Are Associated with Prognosis in Ovarian Cancer

prognostic gene expression index in ovarian cancer--validation across different independent data sets

Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors

An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian Carcinoma

Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cells

Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients

The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer

Altered Expression Pattern of Topoisomerase IIα, in Ovarian Tumor Epithelial and Stromal Cells after Platinum-Based Chemotherapy

Pelvic Exenteration in Advanced Gynecologic Malignancies – Who Will Benefit?

Anterior enterocele after cystectomy: case report and review of the literature

Soluble heat-shock protein 27 in blood serum is a non-invasive prognostic biomarker for ovarian cancer

Risk Factors for Severe Complications in Ovarian Cancer Surgery

Analysis of heat shock protein HSP27 secretion in an ovarian cancer cell model and detection of cell-free HSP27 in patient blood serum sample

Polymorphism of IL-1α, IL-1β and IL-10 in patients with advanced ovarian cancer: Results of a prospective study with 147 patients

Topoisomerase IIα mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis

The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patterns

Expression of multidrug resistance-associated protein 1 in invasive ovarian carcinoma: implication for prognosis

Expression of IL-10 in Patients with Ovarian Carcinoma

Bildgebung des Beckenbodens: Die Sicht der Gynäkologie

Lower Genital Tract Melanomas: Staging, Predictors of Outcome, and New Therapeutic Options

Polymorphism of IL-1 receptor antagonist gene: role in cancer

Topoisomerase II mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis

Polymorphism of IL-1alpha, IL-1beta and IL-10 in patients with advanced ovarian cancer: results of a prospective study with 147 patients

Altered Expression Pattern of Topoisomerase IIα in Ovarian Tumor Epithelial and Stromal Cells after Platinum-Based Chemotherapy1

Preoperative determination of CASA (Cancer Associated Serum Antigen) and CA-125 for the discrimination between benign and malignant pelvic tumor mass: a prospective study

Suchergebnisse filtern